From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July ...

CHENNAI: Gilead Sciences has achieved another milestone in its efforts to bring in a preventive drug to curb the still ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and low-resource settings, marking a major step in fighting global HIV spread.

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for ...

Rahway, New Jersey Wednesday, July 16, 2025, 17:30 Hrs [IST] ...

The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, ...

Devastating funding cuts from international donors are hitting countries hardest affected by HIV | One of India's leading Digital News Agency offering Breaking News round the clock. Why not read our ...

UNAIDS Warns Funding Collapse Puts Decades of HIV Progress at RiskThe Joint United Nations Programme on HIV/AIDS (UNAIDS) has warned that decades of progress in addressing AIDS are at risk after a ...

US cuts could lead to four million AIDS-related deaths by 2029, according to UN officials. View on euronews ...